Lewis L. Judd, M.D.
2009 Falcone Prize for Outstanding Achievement in Affective Disorders Research (Colvin Prize)
Lewis L. Judd, M.D.
Mary Gilman Marston Professor
Distinguished Professor of Psychiatry
Chair, Department of Psychiatry
At UCSD, where he has taught for over 35 years, Dr. Judd directs basic and clinical research focused on severe brain and behavior disorders throughout the life cycle. His department centers on mood disorders, late-onset psychoses, neurobehavioral aspects of HIV infection, child and adolescent services research and many other clinical and basic research programs. His research has centered on the course, recovery and outcome of mood and anxiety disorders and their management by psychopharmacologic medications.
As former Director of the NIMH from 1987 to 1990, Dr. Judd led national plans for research in schizophrenia and disorders in children and adolescents and for improved services for those with severe mental illness. He designed and led “The Decade of the Brain,” a plan launched as a Presidential proclamation to increase the neuroscience capacity of the nation.
Learn More About the Foundation
The Brain & Behavior Research Foundation is a global nonprofit organization focused on improving the understanding, prevention and treatment of psychiatric and mental illnesses.
Beginning in 1987, the Brain & Behavior Research Foundation was providing seed money to neuroscientists to invest in “out of the box” research that the government and other sources were unwilling to fund. Today, Brain & Behavior Research Foundation is still the leading, private philanthropy in the world in this space.
Meet the people who make up the Brain & Behavior Research Foundation. Our staff of experts, passionate Board of Directors, and Scientific Council which includes Nobel prize winners and chairs of psychiatric departments around the world.
We take our responsibility to our donors seriously and believe that our financial operations must be transparent. We're proud to say that 100% of your contribution for research is invested directly in research grants.